Literature DB >> 6155345

Macrophage dependence of polyriboinosinic acid-polyribocytidylic acid-induced resistance to herpes simplex virus infection in mice.

D Martinez, R J Lynch, J B Meeker, A K Field.   

Abstract

The relative contributions of macrophages and lymphocytes to the induction of resistance to primary herpes simplex virus type 1 (HSV-1) infection by polyriboinosinic-polyribocytidylic acid complex [poly (I:C)] were investigated in C58 mice. The induction of resistance was found to be strongly dependent on macrophages compared to lymphocytes. Macrophage-deficient (silica-treated) mice produced less interferon and were not as responsive to prophylactic treatment of HSV-1 infections with poly (I:C) as were either normal, lymphocyte-deficient (cyclophosphamide-treated), or T-lymphocyte-deficient (anti-thymocyte serum-treated, adult-thymectomized) mice. Silica and cyclophosphamide treatments reduced the therapeutic activity of poly (I:C), whereas T-cell depletion did not have a significant effect. Similarly, the protection of mice with exogenous interferon was markedly reduced in silica-treated mice and moderately reduced in cyclophosphamide-treated mice, but unaffected in T-cell-deficient mice. Furthermore, suppression of HSV-1 plaque formation was obtained by cocultivation of infected mouse fibroblast monolayers with peritoneal (macrophage-rich) cells, but not with splenic (lymphocyte-rich) cells, from poly (I:C)-treated mice. Peritoneal cells did not protect heterologous (human) fibroblasts, suggesting that the protection of mouse embryo fibroblasts is mediated by interferon. Collectively, the data indicate that macrophages are required for the production of poly (I:C)-induced interferon and that macrophages and perhaps B-lymphocytes are important for mediating the protection against HSV-1 infection after interferon has been produced.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155345      PMCID: PMC550904          DOI: 10.1128/iai.28.1.147-153.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Prophylactic and therapeutic use of poly(I)-poly(C) (poly-D-lysine) against herpesvirus encephalitis in mice.

Authors:  L W Catalano; W T London; J M Rice; J L Sever
Journal:  Proc Soc Exp Biol Med       Date:  1972-05

2.  Effect of antilymphocytic serum on circulating interferon in mice as a function of the inducer.

Authors:  J de Maeyer-Guignard; E de Maeyer
Journal:  Nat New Biol       Date:  1971-02-17

3.  Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice.

Authors:  B Zisman; M S Hirsch; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

4.  Inducers of interferon and host resistance, V. In vitro studies.

Authors:  A K Field; A A Tytell; G P Lampson; M R Hilleman
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

5.  Differential effects of cyclophosphamide on the B and T cell compartments of adult mice.

Authors:  G D Stockman; L R Heim; M A South; J J Trentin
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

6.  Therapeutic use of inducers of interferon on Herpes simplex keratitis in humans.

Authors:  M A Galin; E Chowchuvech; B Kronenberg
Journal:  Ann Ophthalmol       Date:  1976-01

7.  Resistance of C58 mice to primary systemic herpes simplex virus infection: macrophage dependence and T-cell independence.

Authors:  A J Schlabach; D Martinez; A K Field; A A Tytell
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

8.  Immune mechanisms in leukemia: suppression of cellular immunity by drugs and x-irradiation.

Authors:  D Martinez; O A Lukasewycz; W H Murphy
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

9.  Herpesvirus hominis infection in newborn mice: treatment with interferon inducer polyinosinic-polycytidylic acid.

Authors:  E R Kern; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

10.  THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. II. A CELLULAR BASIS FOR THE DEVELOPMENT OF RESISTANCE WITH AGE.

Authors:  R T JOHNSON
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307

View more
  3 in total

1.  Macrophage antiviral activity: extrinsic versus intrinsic activity.

Authors:  S A Stohlman; J G Woodward; J A Frelinger
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

2.  Early interactions of herpes simplex virus with mouse peritoneal macrophages.

Authors:  B Svennerholm; A Vahlne; E Lycke
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

3.  Poly(I.C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis.

Authors:  J Jensen; A Vazquez-Torres; E Balish
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.